Sandy Sheble-Hall

Pilot Study of Saquinavir and Lopinavir/Ritonavir Twice Daily in Protease Inhibitor-Naive HIV-Positive Patients

C. Cohen, Danielle M Gordon, L. Jackson-Pope, 2005, HIV clinical trials.

Relationship Between Plasma Protease Inhibitor Concentrations and Lipid Elevations in HIV Patients on a Double‐Boosted Protease Inhibitor Regimen (Saquinavir/Lopinavir/Ritonavir)

D. Greenblatt, C. Cohen, M. Rhee, 2010, Journal of clinical pharmacology.